First-In-Class Bronchiectasis Treatment Among 14 Drugs Awaiting EMA Verdict

 
• By Vibha Sharma
  
Evaluating the pros and cons of a business contract. Debate and compromise about a business deal. Dispute about the positive and negative aspects.
Sponsors of 14 new drugs could learn if their products are on track for EU-wide approval (Shutterstock)

More from EU CHMP

More from Product Reviews